Iron oxide/hydroxide nanoparticles with negatively charged shells show increased uptake in Caco-2 cells

Molecular Pharmaceutics

Volumn 9, Issue 6, 2012, Pages 1628-1637

  Jahn, Markus R ^a   Nawroth, Thomas ^a   Fütterer, Sören ^a   Wolfrum, Uwe ^a   Kolb, Ute ^a   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

absorption; Caco 2 cells; iron deficiency; iron oxide hydroxide nanoparticles; oral delivery

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CARBOHYDRATE; FERRIC CHLORIDE; FERRIC HYDROXIDE; FERRIC ION; FERROUS ION; FERROUS SULFATE; FERROZINE; IRON OXIDE; METAL NANOPARTICLE;

ALKALINITY; ARTICLE; BIOAVAILABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG UPTAKE; ENDOCYTOSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; PH; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

CACO-2 CELLS; CHLORIDES; FERRIC COMPOUNDS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES;

EID: 84862013527     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200628u     Document Type: Article

References (39)

1. Heinrich, H. C. Bioavailability and Therapeutic Efficacy of Oral Iron(II)- and Iron(III) Preparations. Dtsch. Apoth. Ztg. 1986, 126, 681-690. (Pubitemid 16102271)
2. Gillooly, M.; Bothwell, T. H.; Torrance, J. D.; MacPhail, A. P.; Derman, D. P.; Bezwoda, W. R.; Mills, W.; Charlton, R. W.; Mayet, F. The Effects of Organic Acids, Phytates and Polyphenols on the Absorption of Iron from Vegetables. Br. J. Nutr. 2007, 49, 331-342.
3. Hallberg, L. Bioavailability of Dietary Iron in Man. Annu. Rev. Nutr. 1981, 1, 123-147.
4. Ammon, H. P. T. Arzneimittelneben- und - wechselwirkungen; Wissenschaftliche Verlagsgesellschaft: Stuttgart, 2001; pp 859-871.
5. Geisser, P. Iron Therapy and Oxidative Stress. Met.-Based Drugs 1997, 4, 137-152. (Pubitemid 27351189)
6. Halliwell, B.; Gutteridge, J. M. Role of Free Radicals and Catalytic Metal Ions in Human Disease: An Overview. Methods Enzymol. 1990, 186, 1-85. (Pubitemid 20279941)
7. Seligman, P. A.; Moore, G. M.; Schleicher, R. B. Clinical Studies of Hip: An Oral Heme-Iron Product. Nutr. Res. (N.Y.) 2000, 20, 1279-1286.
8. Jahn, M. R.; Mrestani, Y.; Langguth, P.; Neubert, R. H. H. CE Characterization of Potential Toxic Labile Iron in Colloidal Parenteral Iron Formulations Using Off-Capillary and on-Capillary Complexation with EDTA. Electrophoresis 2007, 28, 2424-2429. (Pubitemid 47162937)
9. Jahn, M. R.; Andreasen, H. B.; Fütterer, S.; Nawroth, T.; Schünemann, V.; Kolb, U.; Hofmeister, W.; Muñoz, M.; Bock, K.; Meldal, M.; Langguth, P. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur. J. Pharm. Biopharm. 2011, 78, 480-491.
10. Geisser, P. Safety and Efficacy of Iron (III)-Hydroxide Polymaltose Complex: A Review of over 25 Years Experience. Arzneim.-Forsch. 2007, 57, 439-452. (Pubitemid 47055995)
11. Geisser, P.; Muller, A. Pharmacokinetics of Iron Salts and Ferric Hydroxide-Carbohydrate Complexes. Arzneim.-Forsch. 1987, 37, 100- 104.
12. Lundqvist, H.; Sjöberg, F. Food Interaction of Oral Uptake of Iron: A Clinical Trial Using 59Fe. Arzneim.-Forsch. 2007, 57, 401-416. (Pubitemid 47055991)
13. Burckhardt-Herold, S.; Klotz, J.; Funk, F.; Büchi, R.; Petrig- Schaffland, J.; Geisser, P. Interactions between Iron (III)-Hydroxide Polymaltose Complex and Commonly Used Drugs: Simulations and in Vitro Studies. Arzneim.-Forsch. 2007, 57, 360-369. (Pubitemid 47055986)
14. Potgieter, M. A.; Pretorius, S. G.; Jacobs, Y. L.; Venter, C.; Venter, J. L.; Geisser, P. Effect of an Oral Iron(III)-Hydroxide Polymaltose Complex on Tetracycline Pharmacokinetics in Patients with Iron Deficiency Anemia. Arzneim.-Forsch. 2007, 57, 385-391. (Pubitemid 47055989)
15. Potgieter, M. A.; Potgieter, J. H.; Venter, C.; Venter, J. L.; Geisser, P. Effect of Oral Aluminium Hydroxide on Iron Absorption from Iron(III)-Hydroxide Polymaltose Complex in Patients with Iron Deficiency Anemia/a Single-Centre Randomized Controlled Isotope Study. Arzneim.-Forsch. 2007, 57, 392-400. (Pubitemid 47055990)
16. Toblli, J. E.; Brignoli, R. Iron(III)-Hydroxide Polymaltose Complex in Iron Deficiency Anemia/Review and Meta-Analysis. Arzneim.-Forsch. 2007, 57, 431-438. (Pubitemid 47055994)
17. Jung, T.; Kamm, W.; Breitenbach, A.; Kaiserling, E.; Xiao, J. X.; Kissel, T. Biodegradable Nanoparticles for Oral Delivery of Peptides: Is There a Role for Polymers to Affect Mucosal Uptake? Eur. J. Pharm. Biopharm. 2000, 50, 147-160. (Pubitemid 30326694)
18. Schipper, N. G.; Olsson, S.; Hoogstraate, J. A.; deBoer, A. G.; Varum, K. M.; Artursson, P. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement. Pharm. Res. 1997, 14, 923-929.
19. Kriwet, B.; Kissel, T. Poly (Acrylic Acid) Microparticles Widen the Intercellular Spaces of Caco-2 Cell Monolayers: An Examination by Confocal Laser Scanning Microscopy. Eur. J. Pharm. Biopharm. 1996, 42, 233-240. (Pubitemid 26294953)
20. Sun, C.; Lee, J. S. H.; Zhang, M. Magnetic Nanoparticles in MR Imaging and Drug Delivery. Adv. Drug Delivery Rev. 2008, 60, 1252- 1265.
21. Hussain, N.; Jani, P. U.; Florence, A. T. Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat. Pharm. Res. 1997, 14, 613-618. (Pubitemid 27220279)
22. Russell-Jones, G. J.; Arthur, L.; Walker, H. Vitamin B12- Mediated Transport of Nanoparticles across Caco-2 Cells. Int. J. Pharmaceutics 1999, 179, 247-255. (Pubitemid 29131434)
23. Chalasani, K. B.; Russell-Jones, G. J.; Yandrapu, S. K.; Diwan, P. V.; Jain, S. K. A Novel Vitamin B12-Nanosphere Conjugate Carrier System for Peroral Delivery of Insulin. J. Controlled Release 2007, 117, 421-429. (Pubitemid 46237606)
24. Jahn, M. R.; Shukoor, I.; Tremel, W.; Wolfrum, U.; Kolb, U.; Nawroth, T.; Langguth, P. Hemin-coupled iron(III)-hydroxide nanoparticles show increased uptake in Caco-2 cells. J. Pharm. Pharmacol. 2011, 63, 1522-1530.
25. Jani, P.; Halbert, G. W.; Langridge, J.; Florence, A. T. Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency. J. Pharm. Pharmacol. 1990, 42, 821- 826.
26. Tandy, S.; Williams, M.; Leggett, A.; Lopez-Jimenez, M.; Dedes, M.; Ramesh, B.; Srai, S. K.; Sharp, P. Nramp2 Expression Is Associated with pH-dependent Iron Uptake across the Apical Membrane of Human Intestinal Caco-2 Cells. J. Biol. Chem. 2000, 275, 1023-1029. (Pubitemid 30051149)
27. Latunde-Dada, G. O.; Takeuchi, K.; Simpson, R. J.; McKie, A. T. Haem Carrier Protein 1 (HCP1): Expression and Functional Studies in Cultured Cells. FEBS Lett. 2006, 580, 6865-6870. (Pubitemid 44914141)
28. Desai, M. P.; Labhasetwar, V.; Walter, E.; Levy, R. J.; Amidon, G. L. The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent. Pharm. Res. 1997, 14, 1568-1573. (Pubitemid 28009208)
29. Alvarez-Hernandez, X.; Nichols, G. M.; Glass, J. Caco-2 Cell Line: A System for Studying Intestinal Iron Transport across Epithelial Cell Monolayers. Biochim. Biophys. Acta 1991, 1070, 205-208.
30. Fish, W. W. Rapid Colorimetric Micromethod for the Quantitation of Complexed Iron in Biological Samples. Methods Enzymol. 1988, 158, 357-364.
31. NCL Method GTA-1, Version 1.0, LLC-PK1 Kidney Cytotoxicity Assay; National Cancer Institute: Bethesda, MD, 2005.
32. Eldridge, J. H.; Hammond, C. J.; Meulbroek, J. A.; Staas, J. K.; Gilley, R. M.; Tice, T. R. Controlled Vaccine Release in the Gut- Associated Lymphoid Tissues. I. Orally Administered Biodegradable Microspheres Target the Peyer's Patches. J. Controlled Release 1990, 11, 205-214. (Pubitemid 20070098)
33. Behrens, I.; Pena, A. I. V.; Alonso, M. J.; Kissel, T. Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport. Pharm. Res. 2002, 19, 1185-1193. (Pubitemid 34985003)
34. Mathiowitz, E.; Jacob, J. S.; Jong, Y. S.; Carino, G. P.; Chickering, D. E.; Chaturvedi, P.; Santos, C. A.; Vijayaraghavan, K.; Montgomery, S.; Bassett, M. Biologically Erodable Microspheres as Potential Oral Drug Delivery Systems. Nature 1997, 386, 410-414. (Pubitemid 27154483)
35. Heinrich, H. C.; Fischer, R.; Gabbe, E. E.; Theobald, N. Bioavailability of Trivalent Iron in Oral Iron(III)-Hydroxide-Dextrin (Polymaltose) Complex in Man. J. Mol. Med. 1983, 61, 103-110. (Pubitemid 13182840)
36. Yin Win, K.; Feng, S.-S. Effects of Particle Size and Surface Coating on Cellular Uptake of Polymeric Nanoparticles for Oral Delivery of Anticancer Drugs. Biomaterials 2005, 26, 2713-2722. (Pubitemid 39600724)
37. Ekmekcioglu, C.; Feyertag, J.; Marktl, W. A Ferric Reductase Activity Is Found in Brush Border Membrane Vesicles Isolated from Caco-2 Cells. J. Nutr. 1996, 126, 2209-2217. (Pubitemid 26313598)
38. Han, O.; Failla, M. L.; Hill, A. D.; Morris, E. R.; Smith, J. C., Jr. Reduction of Fe(III) Is Required for Uptake of Nonheme Iron by Caco-2 Cells. J. Nutr. 1995, 125, 1291-1299.
39. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life; WHO: Geneva, 2002; pp 52- 56.